Home › Graves Ophthalmopathy › West Virginia
Graves Ophthalmopathy clinical trials in West Virginia
3 studies for Graves Ophthalmopathy are looking for participants at sites in West Virginia.
Cities in West Virginia
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
- WVU Eye Institute, Morgantown
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07753603An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
- West Virginia University, Morgantown
RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Jul 23, 2026 · NCT07438405Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
- West Virginia University Eye Institute, Morgantown
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Feb 25, 2025 · NCT06112340From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.